Satisfactory Control for Glucose Profile by Combined Agents of Xultophy with A Small Dose-Reference-Cited by-同舟云学术

Satisfactory Control for Glucose Profile by Combined Agents of Xultophy with A Small Dose

Published:2021-06-08 Issue:2 Volume:3 Page:23-29
ISSN:
Container-title:Diabetes Research: Open Access
language:en
Short-container-title:Diab Res Open Access

Author:

Bando Hiroshi¹^ORCID,Ogawa Hiroko²,Nagahiro Shinji²,Nakanishi Miwako²,Watanabe Osami²

Affiliation:

1. Medical Research/Tokushima University, Tokushima, Japan; Japan Low Carbohydrate Diet Promotion Association (JLCDPA), Kyoto, Japan; Yoshinogawa Hospital, Tokushima, Japan

2. Yoshinogawa Hospital, Tokushima, Japan

Abstract

The patient was a 74-year-old female with type 2 diabetes mellitus (T2DM) treated on Humalog mix 25 twice a day. As social history, she has worked long years for growing and harvesting lotus roots. It gives physically heavy loading, which brings unstable glycemic daily control. She had to titrate minute regulation every time. For stable glucose variability, the treatment was changed to Xultophy, which is a specific combined agent of Insulin Degludec and Liraglutide (IDeg/Lira) once a day. Then, detailed glucose monitoring showed a better daily profile of blood glucose, irrespective of heavy or light work. It showed the bio-psycho-social benefit of Xultophy.

Publisher

Asploro Open Access Publications

Reference24 articles.

1. American Diabetes Association. Summary of Revisions: Standards of Medical Care in Diabetes-2021. Diabetes Care. 2021 Jan;44(Suppl 1):S4-S6. [PMID: 33298411]

2. Davies MJ, D’Alessio DA, Fradkin J, Kernan WN, Mathieu C, Mingrone G, Rossing P, Tsapas A, Wexler DJ, Buse JB. Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2018 Dec;41(12):2669-701. [PMID: 30291106]

3. Doyle-Delgado K, Chamberlain JJ, Shubrook JH, Skolnik N, Trujillo J. Pharmacologic Approaches to Glycemic Treatment of Type 2 Diabetes: Synopsis of the 2020 American Diabetes Association’s Standards of Medical Care in Diabetes Clinical Guideline. Ann Intern Med. 2020 Nov 17;173(10):813-21. [PMID: 32866414]

4. American Diabetes Association. 10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes-2021. Diabetes Care. 2021 Jan;44(Suppl 1):S125-S150. [PMID: 33298421]

5. Atkins RC. Dr. Atkins’ New Diet Revolution. New York, NY: Harper; 2009 Dec 29.